AcuraStem
PrivateLast Round
Grant
Apr 28, 2026
Total Funding Raised
$26.73M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
AcuraStem operates in Healthcare & Life Sciences and is based in Pasadena, California. Its latest recorded funding round was a Grant round in April 2026.
AcuraStem is a biotechnology company that develops therapeutics for neurodegenerative diseases using its proprietary iNeuroRx® disease-modeling platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AcuraStem Comparables
Compare AcuraStem with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| NeuCyte | 91% | |
| Stem Pharm | 87% | |
| Quiver Bioscience | 86% |
For institutional investors. Book with your work email.
AcuraStem Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 28, 2026 | ||||
| Grant | Mar 10, 2026 | ||||
| Grant | Sep 3, 2024 | ||||
| Grant | Jan 30, 2024 | ||||
| Seed | Nov 21, 2022 | ||||
Grant | Dec 15, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AcuraStem Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| United States Department of Defense | Grant |
| NIH RADx | Grant |
| Viva BioInnovator | Grant |
| Target ALS | Grant |
| California Institute for Regenerative Medicine | Grant |
| National Institute on Aging | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors grew 157% MoM, reaching 1.5K.
- Apr 28, 2026
$8M grant from California Institute for Regenerative Medicine.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- receives_financingOct 27, 2026
On Oct 27th '26, AcuraStem Inc. receives a two-year $1M award from the ALS Association to develop biomarkers for AS-241's planned first-in-human Phase 1 trial.
- receives_awardOct 27, 2026
AcuraStem Inc. receives a two-year, $1 million Hoffman ALS Clinical Trial Award from the ALS Association to support biomarker development for the first-in-human Phase 1 trial of AS-241, the lead candidate in its UNC13A program, in California on Oct 27th '26.
For institutional investors. Book with your work email.
AcuraStem Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AcuraStem's valuation, stock price, and market status.
Is AcuraStem a public or private company?
AcuraStem is a private company.
What is the current stock price of AcuraStem?
AcuraStem is a private company, so its shares have no public market price. Caplight tracks AcuraStem's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AcuraStem worth (valuation)?
Valuation information for AcuraStem is not publicly available.
Can I buy AcuraStem stock?
AcuraStem shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AcuraStem's last funding round?
AcuraStem's most recent funding round was Grant on April 28, 2026.
Who are the main investors in AcuraStem?
Key investors in AcuraStem include Viva BioInnovator, Keiretsu Forum Midwest.
Will AcuraStem IPO soon?
No public IPO plans have been announced for AcuraStem.
How can I track AcuraStem secondary market activity?
Caplight tracks bids, offers, and trades in AcuraStem's shares on secondary markets.